Sunshine Biopharma amends bylaws to set quorum at one-third of outstanding shares

Sunshine Biopharma Inc.

Quorum for shareholder meetings now one-third of outstanding common voting stock.
Amendment adopted on April 17, 2023; no other bylaw changes disclosed.
Fiscal year unchanged; no impact on capital structure or business operations.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Sunshine Biopharma Inc.: Amendment to bylaws changing the quorum requirement for common voting stock to one-third of outstanding shares (effective 2023-04-17).

Change: bylaw amendment
Effective: 2023-04-17

Exact text from the filing

On April 17, 2023, Sunshine Biopharma, Inc. (the “Company”) adopted an amendment to the Company’s bylaws. Pursuant to the amendment, one-third of the outstanding shares of the Company's common voting stock will constitute a quorum.

View on SEC.gov

Browse all governance changes →

Sunshine Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-002522

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.